RTX Earns Investor Attention While TRNS And RXO Face Serious Scrutiny

Industrials companies form the backbone of the American economy, yet the sector has broadly underperformed the broader market over the past six months.

The industry’s 5% return lagged the S&P 500 by 8.3 percentage points, a gap that reflects ongoing pressure from volatile macroeconomic conditions affecting capital spending.

Interest rates and shifting demand cycles continue to weigh on industrial businesses, making stock selection within the sector especially critical right now.

Not every company in the space faces the same headwinds, and a handful of high-quality businesses are capable of delivering earnings growth across a range of environments.

Transcat (NASDAQ: TRNS), which serves pharmaceutical, industrial manufacturing, energy, and chemical process industries by providing measurement instruments and supplies, is one stock analysts suggest avoiding.

TRNS has seen its earnings per share fall by 15.9% annually over the past two years, with revenue growth effectively nullified by the company’s new share issuances during that period.

Below-average returns on capital suggest management has struggled to identify compelling investment opportunities, and decreasing returns indicate its historical profit centers may be aging.

Transcat currently trades at $84.35 per share, representing a forward price-to-earnings multiple of 41.8x, a valuation that appears difficult to justify given those underlying trends.

RXO (NYSE: RXO), the freight brokerage platform offering full-truckload, less-than-truckload, and last-mile delivery services with access to millions of trucks, also raises red flags for investors.

The company has seen declining unit sales over the past two years, and its free cash flow margin has dropped by 5.3 percentage points over the last five years as it has invested heavily to defend its market position.

RXO’s liquidity position remains unfavorable, raising the prospect of additional equity financing that could dilute existing shareholders further, adding another layer of risk.

The stock trades at $19.48 per share, implying a valuation ratio of 59.4x forward P/E, a steep premium for a company facing these structural challenges.

On the more promising side of the ledger, RTX (NYSE: RTX), the aerospace and defense giant originally focused on refrigeration technology, stands out as a stock worth watching closely.

Raytheon’s organic revenue growth averaged 10.5% over the past two years, demonstrating that its core business can grow without relying on acquisitions to drive the headline number.

Annual earnings per share growth of 16.3% over the last five years has exceeded revenue gains, reflecting the meaningful impact of the company’s ongoing share repurchase program on shareholder returns.

RTX has also seen its free cash flow margin jump by 5.2 percentage points over the last five years, giving the company greater flexibility to pursue growth initiatives, buy back shares, or pay dividends.

With a market capitalization of $266.4 billion and a current share price of $197.86, RTX trades at 26.9x forward P/E, a valuation that looks far more grounded relative to its consistent financial performance.

For investors navigating a sector under pressure, the contrast between RTX’s durable growth profile and the challenges facing TRNS and RXO illustrates why disciplined stock selection matters more than broad sector exposure.